Article
Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.